SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca


Journal

The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646

Informations de publication

Date de publication:
10 2022
Historique:
revised: 21 03 2022
received: 19 05 2021
accepted: 26 05 2022
pubmed: 29 5 2022
medline: 20 10 2022
entrez: 28 5 2022
Statut: ppublish

Résumé

Post-translational modification of the myofilament protein troponin I by phosphorylation is known to trigger functional changes that support enhanced contraction and relaxation of the heart. We report for the first time that human troponin I can also be modified by SUMOylation at lysine 177. Functionally, TnI SUMOylation is not a factor in the development of passive and maximal force generation in response to calcium, however this modification seems to act indirectly by preventing SUMOylation of other myofilament proteins to alter calcium sensitivity and cooperativity of myofilaments. Utilising a novel, custom SUMO site-specific antibody that recognises only the SUMOylated form of troponin I, we verify that this modification occurs in human heart and that it is upregulated during disease.

Identifiants

pubmed: 35633070
doi: 10.1111/febs.16537
pmc: PMC9588612
mid: NIHMS1825797
doi:

Substances chimiques

Troponin I 0
Lysine K3Z4F929H6
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6267-6285

Subventions

Organisme : British Heart Foundation
ID : PG/21/10363
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL148785
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149164
Pays : United States
Organisme : British Heart Foundation
ID : FS/15/64/32035
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

EMBO Rep. 2014 Aug;15(8):878-85
pubmed: 24891386
Biochem Soc Trans. 2013 Apr;41(2):463-73
pubmed: 23514139
Circ Res. 2018 Aug 31;123(6):673-685
pubmed: 30355233
Circ Res. 2014 May 9;114(10):1561-3
pubmed: 24812349
Cardiovasc Res. 1999 Jun;42(3):706-19
pubmed: 10533611
J Mol Cell Cardiol. 2012 Mar;52(3):638-49
pubmed: 22155005
Science. 2002 Mar 1;295(5560):1711-5
pubmed: 11872839
Cardiovasc Res. 1998 May;38(2):414-23
pubmed: 9709402
Circ Res. 1995 Jun;76(6):1028-35
pubmed: 7758157
Heart Lung Circ. 2016 Apr;25(4):319-24
pubmed: 26795636
Nature. 2011 Sep 07;477(7366):601-5
pubmed: 21900893
Circulation. 1997 Sep 2;96(5):1495-500
pubmed: 9315537
Nat Commun. 2015 Jun 12;6:7229
pubmed: 26068603
Nat Commun. 2020 Jan 9;11(1):153
pubmed: 31919429
Mol Ther. 2017 Mar 1;25(3):666-678
pubmed: 28143738
Cardiovasc Res. 2005 Apr 1;66(1):12-21
pubmed: 15769444
Cardiovasc Res. 2003 Jan;57(1):37-47
pubmed: 12504812
Toxicol Appl Pharmacol. 2018 Apr 15;345:1-9
pubmed: 29524504
J Cell Sci. 2010 Aug 15;123(Pt 16):2823-33
pubmed: 20663916
Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1644-50
pubmed: 23564307
Wiley Interdiscip Rev Syst Biol Med. 2011 Jul-Aug;3(4):446-57
pubmed: 21197655
Circ Res. 2004 Mar 5;94(4):496-504
pubmed: 14726477
PLoS One. 2019 Apr 11;14(4):e0213331
pubmed: 30973885
Nat Methods. 2007 Mar;4(3):245-50
pubmed: 17277783
Circulation. 1999 Feb 2;99(4):505-10
pubmed: 9927396
Toxicol Sci. 2016 Dec;154(2):320-331
pubmed: 27621282
Sci Transl Med. 2013 Nov 13;5(211):211ra159
pubmed: 24225946
Toxicology. 2010 Dec 30;278(3):288-93
pubmed: 20674646
Biochim Biophys Acta. 2015 Jul;1852(7):1388-99
pubmed: 25857621
Nature. 1976 Aug 12;262(5569):615-7
pubmed: 958429
Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H260-8
pubmed: 23144315
Yale J Biol Med. 2005 Jul;78(4):197-201
pubmed: 16720014
PLoS One. 2013;8(1):e54214
pubmed: 23382880
J Physiol. 2003 Nov 1;552(Pt 3):845-57
pubmed: 12923217
Cardiovasc Res. 2000 Jan 14;45(2):397-409
pubmed: 10728360
Circ Res. 2004 Feb 6;94(2):146-58
pubmed: 14764650
VAD J. 2016;2(1):
pubmed: 28042604
Biochem J. 2006 Aug 15;398(1):23-36
pubmed: 16689683
J Cell Sci. 2009 Aug 1;122(Pt 15):2623-31
pubmed: 19567471
J Vis Exp. 2014 Apr 25;(86):
pubmed: 24796715
Int J Cardiol. 2018 Apr 15;257:283-290
pubmed: 29180262
Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1292-H1300
pubmed: 31584834
Nat Rev Mol Cell Biol. 2001 Mar;2(3):202-10
pubmed: 11265250
Nature. 2002 Jan 10;415(6868):198-205
pubmed: 11805843
Methods Mol Biol. 2009;497:3-16
pubmed: 19107407
BMC Cell Biol. 2018 Nov 12;19(1):24
pubmed: 30419807
Circulation. 1995 Aug 15;92(4):778-84
pubmed: 7641356
Cell Rep. 2020 Feb 18;30(7):2225-2236.e4
pubmed: 32075761

Auteurs

Bracy Fertig (B)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Jiayue Ling (J)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Edgar E Nollet (EE)

Department of Physiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, The Netherlands.

Sara Dobi (S)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Tara Busiau (T)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Kiyotake Ishikawa (K)

Cardiovascular Research Centre, Icahn School of Medicine, New York, NY, USA.

Kelly Yamada (K)

Cardiovascular Research Centre, Icahn School of Medicine, New York, NY, USA.

Ahyoung Lee (A)

Cardiovascular Research Centre, Icahn School of Medicine, New York, NY, USA.

Changwon Kho (C)

Division of Applied Medicine, Pusan National University, Korea.

Lauren Wills (L)

Department of Neuroscience, Ichan School of Medicine, New York, NY, USA.

Amy J Tibbo (AJ)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Mark Scott (M)

INSERM, U1016, Institut Cochin, Paris, France.

Kirsten Grant (K)

Department of Clinical Biochemistry, Glasgow Royal Infirmary, UK.

Kenneth S Campbell (KS)

Department of Physiology, University of Kentucky, Lexington, KY, USA.
Division of Cardiovasuclar Medicine, University of Kentucky, Lexington, KY, USA.

Emma J Birks (EJ)

Division of Cardiovasuclar Medicine, University of Kentucky, Lexington, KY, USA.

Niall MacQuaide (N)

School of Health and Life Sciences, Glasgow Caledonian University, UK.

Roger Hajjar (R)

Flagship Pioneering, Cambridge, MA, USA.

Godfrey L Smith (GL)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Jolanda van der Velden (J)

Department of Physiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, The Netherlands.
Netherlands Heart Institute, Utrecht, The Netherlands.

George S Baillie (GS)

Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, Glasgow University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH